Cargando…
Emerging trends in sacubitril/valsartan research: A bibliometric analysis of the years 1995–2021
BACKGROUND: Sacubitril/valsartan has been approved for the treatment of heart failure (HF) patients with reduced ejection fraction; since then, it gradually became a new star drug in the therapy of HF. Nevertheless, the effectiveness of sacubitril/valsartan remains under investigation. Thus far, onl...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351920/ https://www.ncbi.nlm.nih.gov/pubmed/35945796 http://dx.doi.org/10.1097/MD.0000000000029398 |